Model:750128762820
Current Reviews:0
Price:$24.00
Lincocin 500mg 16 Caps, Lincomycin
THIS IS A BRAND MEDICATION
INDICATIONS
Lincocin ® has proven effective in treating the following infections when caused by susceptible strains of Gram-positive aerobes such as streptococci, staphylococci and pneumococci, or susceptible anaerobic bacteria.
Infections of the upper airways, including tonsillitis, pharyngitis, sinusitis, otitis media, scarlet fever and as a supportive therapy for diphtheria. The effectiveness in the treatment of mastoiditis is predictable.
Infections of the lower respiratory tract, including acute bronchitis, chronic pneumonia.
Infections of skin and soft tissue, including boils, cellulitis, impetigo, abscesses, acne and wound infections. Conditions such as erysipelas, lymphadenitis, paronychia (panaritium) skin and gangrene mastitis, may respond to therapy with lincomycin, if caused by susceptible organisms.
Infections of the bone and joints, including osteomyelitis and septic arthritis.
Septicemia and endocarditis: Selected cases of septicemia and / or endocarditis, caused by susceptible organisms, have responded well to lincomycin. However, often bactericidal drugs are preferred for these infections.
Bacillary dysentery: Although Shigella is resistant to lincomycin in vitro (MIC approximately 200-400 mg / ml), lincomycin has been effective in treatment due to very high levels of lincomycin achieved in the intestine (approximately 3.000 to 7.000 mg / gram of feces).
CONTRAINDICATIONS
Lincomycin is contraindicated in patients who have previously found sensitive to lincomycin or clindamycin or any other part of the formula.
GENERAL RECAUTIONS
Pseudomembranous colitis has been reported with nearly all antibacterial agents, including lincomycin, and can vary in severity from mild to life-threatening. Therefore, it is important to consider the diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents.
Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated colitis. After you have established a primary diagnosis of pseudomembranous colitis, therapeutic measures should be initiated. In moderate to severe cases, consideration should be given management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against Clostridium difficile colitis.
Although lincomycin appears that diffuses into the cerebrospinal fluid levels of lincomycin herein may be unsuitable for the treatment of meningitis. Therefore, the drug should not be used in the treatment of meningitis.
If lincomycin therapy is prolonged, tests for liver function and kidney function.
The use of antibiotics can result in an overgrowth of nonsusceptible organisms, particularly fungi.
Lincomycin should not be injected I.V. as a bolus, but should be infused as described in section Dosage and administration.
DOSAGE AND ADMINISTRATION
Intramuscular injection
1) 600 mg I.M. every 24 hours.
2) More severe infections: 600 mg I.M. every 12 hours (or more frequent) according to the severity of the infection.
Intravenous infusion: intravenous doses are administered based on 1 g of lincomycin diluted in at least 100 ml of the appropriate solution and infused over a period of not less than 1 hour.
Note: Severe cardiopulmonary reactions have occurred when this drug has been administered in concentrations and infusion rates higher than what is recommended:
1) From 600 mg to 1 g every 8 or 12 hours.
2) For more severe infections, these doses can be increased.
3) In situations of risk to life, have been given daily intravenous doses up to 8 g
Drug Name: Lincocin
Comparable Patent Medicines: Lincocin
Active substance: Lincomycin
Presentation: Injectable Sun
Concentration: 600mg/2ml
Extended-release tablets: No
Laboratory PFIZER SA de CV
Bottle with 6 prefilled syringes with 2 ml
In blisterpack
Made in: Belgium